James MH - Search Results

1

Introduction to the Special Issue: "Making orexin-based therapies for addiction a reality: What are the steps from here?".

James MH, Aston-Jones G. James MH, et al. Brain Res. 2020 Mar 15;1731:146665. doi: 10.1016/j.brainres.2020.146665. Epub 2020 Jan 10. Brain Res. 2020. PMID: 31930996 Free PMC article. No abstract available.

2

Differential roles of medial prefrontal subregions in the regulation of drug seeking.

Moorman DE, James MH, McGlinchey EM, Aston-Jones G. Moorman DE, et al. Among authors: james mh. Brain Res. 2015 Dec 2;1628(Pt A):130-46. doi: 10.1016/j.brainres.2014.12.024. Epub 2014 Dec 18. Brain Res. 2015. PMID: 25529632 Free PMC article. Review.

3

Orexin/hypocretin-1 receptor antagonism reduces ethanol self-administration and reinstatement selectively in highly-motivated rats.

Moorman DE, James MH, Kilroy EA, Aston-Jones G. Moorman DE, et al. Among authors: james mh. Brain Res. 2017 Jan 1;1654(Pt A):34-42. doi: 10.1016/j.brainres.2016.10.018. Epub 2016 Oct 19. Brain Res. 2017. PMID: 27771284 Free PMC article.

4

A Decade of Orexin/Hypocretin and Addiction: Where Are We Now?

James MH, Mahler SV, Moorman DE, Aston-Jones G. James MH, et al. Curr Top Behav Neurosci. 2017;33:247-281. doi: 10.1007/7854_2016_57. Curr Top Behav Neurosci. 2017. PMID: 28012090 Free PMC article. Review.

5

Role of the Orexin/Hypocretin System in Stress-Related Psychiatric Disorders.

James MH, Campbell EJ, Dayas CV. James MH, et al. Curr Top Behav Neurosci. 2017;33:197-219. doi: 10.1007/7854_2016_56. Curr Top Behav Neurosci. 2017. PMID: 28083790 Review.

6

Orexin/Hypocretin, Central Amygdala, and Escalation of Cocaine Intake.

James MH, Aston-Jones G. James MH, et al. Biol Psychiatry. 2017 Apr 1;81(7):552-553. doi: 10.1016/j.biopsych.2017.01.010. Biol Psychiatry. 2017. PMID: 28283054 Free PMC article. No abstract available.

7

Increased Number and Activity of a Lateral Subpopulation of Hypothalamic Orexin/Hypocretin Neurons Underlies the Expression of an Addicted State in Rats.

James MH, Stopper CM, Zimmer BA, Koll NE, Bowrey HE, Aston-Jones G. James MH, et al. Biol Psychiatry. 2019 Jun 1;85(11):925-935. doi: 10.1016/j.biopsych.2018.07.022. Epub 2018 Aug 7. Biol Psychiatry. 2019. PMID: 30219208 Free PMC article.

8

Demand elasticity predicts addiction endophenotypes and the therapeutic efficacy of an orexin/hypocretin-1 receptor antagonist in rats.

James MH, Bowrey HE, Stopper CM, Aston-Jones G. James MH, et al. Eur J Neurosci. 2019 Aug;50(3):2602-2612. doi: 10.1111/ejn.14166. Epub 2018 Oct 14. Eur J Neurosci. 2019. PMID: 30240516 Free PMC article.

9

Activation of lateral hypothalamic group III metabotropic glutamate receptors suppresses cocaine-seeking following abstinence and normalizes drug-associated increases in excitatory drive to orexin/hypocretin cells.

Yeoh JW, James MH, Adams CD, Bains JS, Sakurai T, Aston-Jones G, Graham BA, Dayas CV. Yeoh JW, et al. Among authors: james mh. Neuropharmacology. 2019 Aug;154:22-33. doi: 10.1016/j.neuropharm.2018.09.033. Epub 2018 Sep 22. Neuropharmacology. 2019. PMID: 30253175 Free PMC article.

10

The orexin-1 receptor antagonist SB-334867 reduces motivation, but not inhibitory control, in a rat stop signal task.

Wiskerke J, James MH, Aston-Jones G. Wiskerke J, et al. Among authors: james mh. Brain Res. 2020 Mar 15;1731:146222. doi: 10.1016/j.brainres.2019.04.017. Epub 2019 Apr 16. Brain Res. 2020. PMID: 31002819 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results